Production (Stage)
Cognition Therapeutics, Inc.
CGTX
$0.322
$0.02377.95%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -33.30M | -33.97M | -34.27M | -31.08M | -28.77M |
| Total Depreciation and Amortization | 253.00K | 266.00K | 261.00K | 256.00K | 250.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 3.16M | 3.94M | 4.48M | 4.66M | 4.53M |
| Change in Net Operating Assets | -1.22M | 1.29M | 3.98M | 3.31M | 3.43M |
| Cash from Operations | -31.11M | -28.47M | -25.55M | -22.86M | -20.56M |
| Capital Expenditure | -4.00K | -4.00K | -33.00K | -91.00K | -106.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -4.00K | -4.00K | -33.00K | -91.00K | -106.00K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -679.00K | -739.00K | -723.00K | -753.00K | -782.00K |
| Issuance of Common Stock | 14.94M | 25.76M | 15.47M | 15.17M | 17.41M |
| Repurchase of Common Stock | -68.00K | -128.00K | -128.00K | -128.00K | -106.00K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -1.33M | -1.33M | -- | -- | -- |
| Cash from Financing | 12.87M | 23.57M | 14.62M | 14.29M | 16.52M |
| Foreign Exchange rate Adjustments | -- | -- | 0.00 | 1.00K | 0.00 |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -18.24M | -4.91M | -10.96M | -8.66M | -4.14M |